Skip to main content

Post-IPO Equity Companies in San Francisco

Explore 47 post-ipo equity startups based in San Francisco, United States. Access verified founder contact information and fundraising data.

Total Companies
47
Total Funding
$3.0B
Avg Funding
$119.2M
Industries
11

Export 47 Post-IPO Equity Companies in San Francisco

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Consumer Goods
$15.0M
raised

Grove creates and curates high-performing, planet-first home, and personal care products.

Sep 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Finance
$68.5M
raised

Forge is a global private securities marketplace creating an accessible, liquid, and transparent private market.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$20.0M
raised

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Advertising
$300.0M
raised

Volta Charging designs, installs, and maintains a network of electric vehicle charging stations.

Aug 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$175.0M
raised

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 47 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biotechnology
$100.0M
raised

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Autonomous Vehicles
$200.0M
raised

Ouster builds high-resolution digital lidar sensors for industrial automation, smart infrastructure, robotics, and automotive.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Blockchain

Securitize is a technology company that enables digital securities, which are easier to own, simpler to manage, and faster to trade.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$240.0M
raised

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$345.0M
raised

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 47 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$2.0M
raised

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$125.0M
raised

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

May 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$115.0M
raised

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$550K
raised

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Analytics
$70.0M
raised

Spire Global is a space to cloud data analytics company utilizing satellites to provide maritime, aviation, and weather tracking.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 47 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Aerospace
$108.0M
raised

Planet is an aerospace and data analytics company that builds small satellites and delivers information about the changing planet.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$150.0M
raised

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$8.0M
raised

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Apr 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$60.0M
raised

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$200.4M
raised

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 47 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$10.0M
raised

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$240.0M
raised

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Mar 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$175.0M
raised

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Mar 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cryptocurrency
$1.8M
raised

Bullish is a regulated and audited global cryptocurrency exchange that allows users to securely buy, sell, and trade digital assets.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$250.0M
raised

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Feb 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 47 companies

Ready to Connect with Post-IPO Equity Startups in San Francisco?

Get verified founder emails, funding details, and company data for 47 post-ipo equity companies in San Francisco.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked